The value added of chemical and pharmaceutical products in France was 35.54 billion Euros in 2023, indicating ongoing growth. Between 2013 and 2023, the market saw overall positive trends, although there were fluctuations year-on-year. Notably, the value increased substantially during 2015, 2017, 2019, and consistently from 2021 onwards. The compound annual growth rate (CAGR) over the last five years (2018-2023) stands at approximately 1.79%, showing moderate growth.
Looking forward, forecasted data suggests continued growth in value added for this sector. The industry's value is projected to reach 37.78 billion Euros by 2028, with an estimated CAGR of 0.97% over the next five years. Although the growth rate moderates slightly, the sector remains on an upward trajectory.
Future trends to watch for include advancements in biotechnology and pharmaceuticals, increased investment in sustainable and green chemistry, and the potential impacts of regulatory changes. Additionally, the sector's adaptation to digital transformation and innovation in drug development will be crucial in driving future growth.
